Sunday, October 20

Tag: Demergers

Bayer CEO Says Breakup Wouldn’t Fix All of the Company’s Ills
25Nov By adminNo Comments
World

Bayer CEO Says Breakup Wouldn’t Fix All of the Company’s Ills

BERLIN—Bayer Chief Executive Bill Anderson said the company would bounce back quickly from a recent spate of bad news, and warned that a breakup of the pharmaceutical and agricultural company was no universal cure for its ailments.A stream of negative news has rekindled calls from investors for Bayer to unlock value by spinning off its units into separate businesses. But in an interview with The Wall Street Journal this week, Anderson said the company couldn’t be distracted from the tough restructuring to fix the businesses.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Alibaba Scraps Cloud Unit Spinoff, Citing Washington’s Chip Curbs
16Nov By adminNo Comments
Technology

Alibaba Scraps Cloud Unit Spinoff, Citing Washington’s Chip Curbs

Nov. 16, 2023 10:10 am ETSINGAPORE—Washington’s latest curbs on the export of high-performance chips to China are beginning to bite.Alibaba on Thursday said it had scrapped its plan to spin off and list its cloud-computing division, citing the impact of the export controls that took effect late last month. The restrictions “may materially and adversely affect” the cloud business’s ability to offer products and services and to perform under existing contracts, Alibaba said, adding that it would focus on the division’s growth.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Alibaba Scraps Cloud Unit Spinoff, Citing Washington’s Chip Curbs
16Nov By adminNo Comments
World

Alibaba Scraps Cloud Unit Spinoff, Citing Washington’s Chip Curbs

Nov. 16, 2023 10:10 am ETSINGAPORE—Washington’s latest curbs on the export of high-performance chips to China are beginning to bite.Alibaba on Thursday said it had scrapped its plan to spin off and list its cloud-computing division, citing the impact of the export controls that took effect late last month. The restrictions “may materially and adversely affect” the cloud business’s ability to offer products and services and to perform under existing contracts, Alibaba said, adding that it would focus on the division’s growth.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Alibaba’s Spinoff Plans Fall to Earth
16Nov By adminNo Comments
World

Alibaba’s Spinoff Plans Fall to Earth

Alibaba’s shareholders finally got their first dividend. But that may not be enough to compensate for hiccups in its spinoff plan and slowing growth.The Chinese e-commerce giant on Thursday announced its first annual dividend since going public in 2014. The company will dish out around $2.5 billion—but that translates to only a 1.1% dividend yield using Wednesday’s closing price.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Wuxi Biologics Unit’s Hong Kong IPO Closes Order Book a Day Early, Sources Say
9Nov By adminNo Comments
World

Wuxi Biologics Unit’s Hong Kong IPO Closes Order Book a Day Early, Sources Say

A unit of Chinese contract drugmaker Wuxi Biologics closed its order book a day early for its initial public offering and is likely to price the deal at the top of its marketed range, people familiar with the matter said, a rare instance of hot demand in a choppy year for listings in Hong Kong.Wuxi XDC Cayman is set to raise the equivalent of about US$470 million if it prices the IPO at the top end of its marketed price range, at 20.60 Hong Kong dollars (US$2.64) a share, the people said. The Wuxi, China-based company does research, development and manufacturing with a focus on antibody-drug conjugate, a type of medicine for cancer treatment.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Sanofi Plans to Spin Off Consumer-Healthcare Business
27Oct By adminNo Comments
World

Sanofi Plans to Spin Off Consumer-Healthcare Business

Sanofi said it plans to spin off its consumer-healthcare unit into a publicly listed entity, making it the latest pharmaceutical giant to sharpen its focus on prescription medicines by offloading adjacent businesses.The French company said Friday that the spinoff is part of a strategic update that includes increased investment in its pipeline and a cost-savings plan.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More